Member Info for sharehunter3

10,000 share sell ,some one looks to be wanting to hold less shares

if the 5000 share tranches were not being bought so often today again ,this share price likely been lower ,if many of these 5000 share tranches are from one buyer they building up a nice sized holding last week ,and starting of well today again

if agreement signed

any reason not to say who with

is it possible more updates ,or even today if a us company

interested in people views

if agreement signed
why not saying yet
is it possible a second rns might be seen today

In the US, the Company has signed a major distribution agreement for its COVID-19 test with a new global strategic partner. The US is delivering significant sales growth for Novacyt and this new agreement enables the Company to accelerate penetration of its COVID-19 test in this important market. This distribution agreement will focus initially on the US, with the potential to expand into further markets

last hour so often can be interesting to watch with returning buyers

In the US, the Company has signed a major distribution agreement for its COVID-19 test with a new global strategic partner. The US is delivering significant sales growth for Novacyt and this new agreement enables the Company to accelerate penetration of its COVID-19 test in this important market. This distribution agreement will focus initially on the US, with the potential to expand into further markets

has any one any idea, who this might be

9200 share buy ,not sure where buyer from

mms moving buy quotes up slightly again , decent finish still might be seen today
some people might want back in if thinking more news this week

More than 230,000 Covid-19 cases were recorded yesterday ...
https://www.dailymail.co.uk/news/article-8516939/World-Health...
2 hours ago · More than 230,000 Covid-19 cases were recorded yesterday in the darkest 24 hours of the pandemic so far, according to the World Health Organization (WHO). The record-high number of …

Obelix ,had not thought of that ,
encouraging to see the coverage ncyt rns getting ,might be why some of buys currently coming in , had thought been after 1,30 before seeing this buying starting to build for afternoon ,good to see

("Novacyt", the "Company" or the "Group")



Half-Year Trading Update



Sales growth of more than 900%, debt-free and

significantly cashflow positive



Demand for COVID-19 test expected to continue into 2021

how many aim shares posting rns this and the money ncyt coming

still thinking strong afternoon ,as more buyers who have sold be wanting back in before more news

and potentily more us buyer in afternoons this week

after this news ,and possible more news to come

The Company's cash position as at 30 June 2020 was €20 million (£18 million) (cash as at 31 December 2019 of €1.8 million (£1.6 million)).

This strong cash position is after significant investment to meet continued demand for the COVID-19 test expected in the second half of the year. It is also reported after paying down all outstanding debt, making Novacyt debt free for the first time in the Company's history

had been thinking below £20 million and good to see £22million
these buyers currently buying also look pleased with today s news
like how buying currently building again here and Paris

Matt2521
if you look at my posts 25 million and a good rise be seen
really pleased to see 22,5 million today
another strong month
well done to ncyt

Bramley ,also thinking nice find ,you were quicker to post ,
good to see this share now getting this exposure
has been needed
share price more likely to move up more now as more learn of progress here
looking forward to a good finish for share price today and this week

when buying in Paris again '
they were lucky with their timing for buying on Friday
more news will not surprise
if a second rns then be fun to see how this moves

TICKING UP AGAIN ,PARIS

5000 share buyer again , another 5000 share trance bought

demand for testing and more testing
still thinking more of a move up this afternoon
after 1,30pm thinking likely to see more buyer who wanting shares before more news

Demand for the Company's COVID-19 test remains strong, with June sales of €25.4 million (£22.5 million) showing the sixth consecutive month of growth. Certain contracts for the supply of the test have also been extended into the second half of the year and in some cases into 2021. With the daily global incidence of SARS-CoV-2 infections continuing to rise, Novacyt expects significant ongoing demand for COVID-19 testing well into 2021. It is a sad fact that as of 11 July 2020, the number of global cases is more than 12.7 million, an increase of 69% compared to 11 June 2020.